Compare
Merck & vs Prestige Consumer Healthcare (MRK vs PBH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Merck & (MRK) returned +73.9% and Prestige Consumer Healthcare (PBH) -28.2%; so far this year the figures are +39.4% and -30.3%.
Merck & is the larger company by market value, about 177.3 times the size of Prestige Consumer Healthcare.
On trailing earnings, MRK trades at 149.7 times and PBH at 13.3 times.
Revenue grew +4.9% at MRK and +5.1% at PBH over the last year.
MRK yields 2.32%. PBH pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| MRK | PBH | |
|---|---|---|
| Price | $146.73 | $42.98 |
| 1-day | -0.14% | -3.02% |
| YTD | +39.40% | -30.33% |
| 1 year | +73.87% | -28.16% |
| 3 years | +42.66% | -27.78% |
| Market cap | $361.7B | $2.0B |
| P/E | 149.7 | 13.3 |
| P/S | 5.37 | 1.75 |
| P/B | 8.06 | 1.05 |
| Revenue growth | +4.90% | +5.10% |
| EPS growth | -87.10% | -19.80% |
| Gross margin % | 71.8 | 52.5 |
| Net margin % | 3.6 | 13.3 |
| ROE % | 5.5 | 8.0 |
| Debt / equity | 1.20 | 1.07 |
| FCF yield % | 4.1 | 10.5 |
| Dividend yield % | 2.32 | — |
| Beta | 0.18 | 0.45 |
| RSI (14) | 51.3 | 36.7 |
| Technical rating |